Home › Type 2 Diabetes › Virginia
Type 2 Diabetes clinical trials in Virginia
29 studies for Type 2 Diabetes are looking for participants at sites in Virginia.
Cities in Virginia
- Arlington19 studies
- Alexandria5 studies
- Charlottesville4 studies
- Norfolk4 studies
- Newport News4 studies
- Richmond4 studies
- Roanoke3 studies
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- University of Virginia Health System, Charlottesville
Recruiting
Ages 2 to 80 · All sexes · Updated Nov 13, 2026 · NCT07864168A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Tidewater Physicians Multispecialty Group, Newport News
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Seven Corners Medical Center, Falls Church
- Carient Heart and Vascular, Manassas
- York Clinical Research, Norfolk
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07064473A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Manassas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
- Centricity Research Suffolk Primary Care, Suffolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Virginia Nephrology Group, Arlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843485A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- York Clinical Research, LLC, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Washington Center for Weight Management and Research, Arlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Carient Heart & Vascular - Manassas, Manassas
- Carient Heart and Vascular LLC-Reston, Reston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Newport News
- Research Site, Vienna
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Manassas
- Research Site, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Falls Church
- Research Site, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07662213Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Burke Internal Medicine and Research, Burke
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 20, 2026 · NCT07502508Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Manassas Clinical Research Center, Manassas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07527650A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- UVA Health Systems, Charlottesville
RecruitingPhase 3
Ages 10 to 18 · All sexes · Updated Oct 19, 2026 · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Suffolk, Suffolk
- Conquest Research, Vienna
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Manassas Clinical Research Center Inc, Burke
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684144Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Tidewater Physicians Multispecialty Group, Newport News
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Chippenham Johnston Willis Medical Center, Richmond
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Hampton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450Cooking Health-Oriented Meals to Prevent Dementia and Diabetes
- Virginia Tech, Blacksburg
RecruitingHealthy volunteers welcome
Ages 50 to 75 · All sexes · Updated Sep 16, 2026 · NCT07661368AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Carient Heart and Vascular, Manassas
- Dominion Medical Associates, Richmond
- VA Medical Center_Salem, Salem
- and 1 more
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Riverside Family Medicine Residency Program, Newport News
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07521475HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Burke Internal Medicine & Research, Burke
- Tekton Research, Midlothian
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07546929Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
- University of Virginia Center for Diabetes Technology, Charlottesville
Recruiting
Ages 30 to 80 · All sexes · Updated Apr 9, 2026 · NCT05766735Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- University of Virginia, Charlottesville
RecruitingHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Mar 23, 2026 · NCT04791371Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Foot and Ankle Specialists of the Mid-Atlantic, Salem
Recruiting
Ages 18 and older · All sexes · Updated Feb 10, 2025 · NCT06681428From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.